These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 3171182)
1. In vivo modulation of myelopoiesis by prostaglandin E2. IV. Prostaglandin E2 induction of myelopoietic inhibitory activity. Gentile PS; Pelus LM J Immunol; 1988 Oct; 141(8):2714-20. PubMed ID: 3171182 [TBL] [Abstract][Full Text] [Related]
2. In vivo modulation of myelopoiesis by prostaglandin E2. II. Inhibition of granulocyte-monocyte progenitor cell (CFU-GM) cell-cycle rate. Gentile PS; Pelus LM Exp Hematol; 1987 Feb; 15(2):119-26. PubMed ID: 3469103 [TBL] [Abstract][Full Text] [Related]
3. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium. De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580 [TBL] [Abstract][Full Text] [Related]
4. In vivo modulation of myelopoiesis by prostaglandin E2. III. Induction of suppressor cells in marrow and spleen capable of mediating inhibition of CFU-GM proliferation. Pelus LM; Gentile PS Blood; 1988 Jun; 71(6):1633-40. PubMed ID: 3163505 [TBL] [Abstract][Full Text] [Related]
5. Blockade of prostaglandin biosynthesis in intact mice dramatically augments the expansion of committed myeloid progenitor cells (colony-forming units-granulocyte, macrophage) after acute administration of recombinant human IL-1 alpha. Pelus LM J Immunol; 1989 Dec; 143(12):4171-9. PubMed ID: 2592770 [TBL] [Abstract][Full Text] [Related]
6. In vivo modulation of murine myelopoiesis following intravenous administration of prostaglandin E2. Gentile P; Byer D; Pelus LM Blood; 1983 Nov; 62(5):1100-7. PubMed ID: 6578856 [TBL] [Abstract][Full Text] [Related]
7. Enhanced hematopoiesis in sublethally irradiated mice treated with various quinolones. Shalit I; Kletter Y; Weiss K; Gruss T; Fabian I Eur J Haematol; 1997 Feb; 58(2):92-8. PubMed ID: 9111589 [TBL] [Abstract][Full Text] [Related]
8. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma. Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781 [TBL] [Abstract][Full Text] [Related]
9. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures. Güenechea G; Bueren JA; Maganto G; Tuduri P; Guerrero A; Pivel JP; Real A Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471 [TBL] [Abstract][Full Text] [Related]
10. Effect of L-phenylalanine methyl ester on the colony formation of hematopoietic progenitor cells from human bone marrow. Chau WK; Law P Int J Cell Cloning; 1991 May; 9(3):211-9. PubMed ID: 2061621 [TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haemopoietic progenitor cells. Ohmori M; Ohmori S; Ueda Y; Tohyama K; Yoshida Y; Uchino H Br J Haematol; 1990 Feb; 74(2):179-84. PubMed ID: 2180470 [TBL] [Abstract][Full Text] [Related]
12. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors. Broxmeyer HE; Williams DE; Hangoc G; Cooper S; Gentile P; Shen RN; Ralph P; Gillis S; Bicknell DC Blood Cells; 1987; 13(1-2):31-48. PubMed ID: 3499193 [TBL] [Abstract][Full Text] [Related]
13. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1. Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587 [TBL] [Abstract][Full Text] [Related]
14. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
15. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice. Pruijt JF; Lindley IJ; Heemskerk DP; Willemze R; Fibbe WE Stem Cells; 1997; 15(1):50-5. PubMed ID: 9007222 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow failure after hemorrhagic shock. Livingston DH; Gentile PS; Malangoni MA Circ Shock; 1990 Mar; 30(3):255-63. PubMed ID: 2178799 [TBL] [Abstract][Full Text] [Related]
17. Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors. Piacibello W; Ferrero D; Sanavio F; Badoni R; Stacchini A; Severino A; Aglietta M Exp Hematol; 1991 Dec; 19(11):1084-9. PubMed ID: 1752317 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo. Laerum OD; Paukovits WR Exp Hematol; 1984 Jan; 12(1):7-17. PubMed ID: 6230248 [TBL] [Abstract][Full Text] [Related]
19. Inhibitor of granulocyte-macrophage colony formation in plasma of mice rendered aplastic by allogeneic lymph node cells. Chiu KM; Knospe WH Exp Hematol; 1989 May; 17(4):335-9. PubMed ID: 2468513 [TBL] [Abstract][Full Text] [Related]
20. The effect of treatment with budesonide or PGE2 in vitro on allergen-induced increases in canine bone marrow progenitors. Inman MD; Denburg JA; Ellis R; Dahlbäck M; O'Byrne PM Am J Respir Cell Mol Biol; 1997 Nov; 17(5):634-41. PubMed ID: 9374115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]